[go: up one dir, main page]

AU6211294A - Kit for diagnosing an hcg- or hcg fragment-secreting cancer and immunotherapeutical means therefor - Google Patents

Kit for diagnosing an hcg- or hcg fragment-secreting cancer and immunotherapeutical means therefor

Info

Publication number
AU6211294A
AU6211294A AU62112/94A AU6211294A AU6211294A AU 6211294 A AU6211294 A AU 6211294A AU 62112/94 A AU62112/94 A AU 62112/94A AU 6211294 A AU6211294 A AU 6211294A AU 6211294 A AU6211294 A AU 6211294A
Authority
AU
Australia
Prior art keywords
hcg
immunotherapeutical
diagnosing
kit
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62112/94A
Other languages
English (en)
Inventor
Dominique Bellet
Jean-Michel Bidart
Nathalie Rouas-Freiss
Frederic Troalen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon France SAS
Original Assignee
Laboratoire L Lafon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9302820A external-priority patent/FR2702494B1/fr
Priority claimed from FR9312039A external-priority patent/FR2710845B1/fr
Application filed by Laboratoire L Lafon SA filed Critical Laboratoire L Lafon SA
Publication of AU6211294A publication Critical patent/AU6211294A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
AU62112/94A 1993-03-11 1994-03-10 Kit for diagnosing an hcg- or hcg fragment-secreting cancer and immunotherapeutical means therefor Abandoned AU6211294A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR9302820 1993-03-11
FR9302820A FR2702494B1 (fr) 1993-03-11 1993-03-11 Trousse de diagnostic d'un cancer secrétant l'hCG ou des fragments d'hCG et vaccin destiné à l'immunothérapie d'un tel cancer.
FR9312039A FR2710845B1 (fr) 1993-10-08 1993-10-08 Composition destinée à l'immunothérapie d'un cancer sécrétant l'hCG ou des fragments d'hCG.
FR9312039 1993-10-08
PCT/FR1994/000265 WO1994020859A1 (fr) 1993-03-11 1994-03-10 TROUSSE DE DIAGNOSTIC D'UN CANCER SECRETANT L'hCG OU DES FRAGMENTS D'hCG ET MOYENS DESTINES A L'IMMUNOTHERAPIE D'UN TEL CANCER

Publications (1)

Publication Number Publication Date
AU6211294A true AU6211294A (en) 1994-09-26

Family

ID=26230164

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62112/94A Abandoned AU6211294A (en) 1993-03-11 1994-03-10 Kit for diagnosing an hcg- or hcg fragment-secreting cancer and immunotherapeutical means therefor

Country Status (6)

Country Link
EP (1) EP0688432A1 (de)
JP (1) JPH08507604A (de)
AU (1) AU6211294A (de)
CA (1) CA2157868A1 (de)
NZ (1) NZ262435A (de)
WO (1) WO1994020859A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5677275A (en) * 1994-08-05 1997-10-14 The United States Of America As Represented By The Department Of Health And Human Services Treatment of cancer with human chorionic gonadotropin
FR2745638A1 (fr) 1996-03-04 1997-09-05 Roussy Inst Gustave Procede pour la detection de la transformation maligne de cellules humaines
US5968513A (en) * 1996-06-24 1999-10-19 University Of Maryland Biotechnology Institute Method of promoting hematopoiesis using derivatives of human chorionic gonadotropin
US6319504B1 (en) 1996-06-24 2001-11-20 University Of Maryland Biotechnology Institute Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
US5997871A (en) * 1996-06-24 1999-12-07 University Of Maryland Biotechnology Insitute Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin
US6583109B1 (en) 1997-06-24 2003-06-24 Robert C. Gallo Therapeutic polypeptides from β-hCG and derivatives
US7994278B1 (en) 1999-08-06 2011-08-09 Nobel Biosciences Llc Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201770A (en) * 1973-05-07 1980-05-06 The Ohio State University Antigenic modification of polypeptides
US4234561A (en) * 1978-02-06 1980-11-18 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
US4713366A (en) * 1985-12-04 1987-12-15 The Ohio State University Research Foundation Antigenic modification of polypeptides
FR2623715B1 (fr) * 1987-11-26 1990-12-21 Lafon Labor Structures peptidiques, immunogenes les contenant et leurs applications au controle de la fertilite
GB8821507D0 (en) * 1988-09-14 1988-10-12 Cancer Res Campaign Tech Improvements relating to peptides
WO1992007272A1 (en) * 1990-10-17 1992-04-30 Yale University Methods for detecting and following the course of cancer, pregnancy and trophoblastic disease

Also Published As

Publication number Publication date
NZ262435A (en) 1997-05-26
EP0688432A1 (de) 1995-12-27
WO1994020859A1 (fr) 1994-09-15
CA2157868A1 (fr) 1994-09-15
JPH08507604A (ja) 1996-08-13

Similar Documents

Publication Publication Date Title
AU1075695A (en) Method for diagnosing cancer
AU6413794A (en) Burn-in module
AU4529393A (en) Method and kit for testing tumors for drug sensitivity
AU3582797A (en) Automated immunoassay analyzer
AU9039691A (en) Rapid diagnostic device and kit
AU5543494A (en) Method and kit for cancer diagnosis
AU7741894A (en) Reagent kit and analyzer suitable for using it
AU1893095A (en) Sensitive cancer test
AU6256194A (en) Enhanced microtitre plate and immunoassays conducted therein
AU696638B2 (en) Method of assaying antiphospholipid antibody and kit therefor
AU6211294A (en) Kit for diagnosing an hcg- or hcg fragment-secreting cancer and immunotherapeutical means therefor
AU2752897A (en) Formazan-based immunoassay
AU5737490A (en) An arrangement in doors
AU120613S (en) Test kit
AU7797994A (en) An assay device
AU8111994A (en) Coulometric analysis
AU8139594A (en) Microtome
AU6241996A (en) Assay method and assay kit
AU6292494A (en) Immunoassay and immunoassay cell used therefor
GB9208548D0 (en) An immunoassay and test kit
AU3397595A (en) Coin gate
AU6756094A (en) Shuttlecar unloading device
AU626044B2 (en) Indirect agglutination immunoassay and apparatus therefor
AU7795494A (en) An improved illuminated sign
AU7070994A (en) Immunoassay